Clinical Trial Update: Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of AC-1101 topical gel in patients with granuloma annulare has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granuloma Annulare

Drugs mentioned

• AC-1101 Topical Gel

Snippet

Sponsor: TWi Biotechnology, Inc. | Conditions: Granuloma Annulare | Phase 1 | Status: COMPLETED